Allogeneic hematopoietic stem cell transplantation outcome in oldest known surviving patients with Wiskott-Aldrich syndrome

Ariharan Anantharachagan; Sook Yin Loh; Siobhan O Burns; Arian Laurence; Susan Tadros; Eleni Tholouli; Yadanar Lwin; Nicolas Martinez-Calle; P Vaitla; Emma C Morris

doi:10.1016/j.jacig.2023.100191

Allogeneic hematopoietic stem cell transplantation outcome in oldest known surviving patients with Wiskott-Aldrich syndrome

J Allergy Clin Immunol Glob. 2023 Nov 22;3(1):100191. doi: 10.1016/j.jacig.2023.100191. eCollection 2024 Feb.

Authors

Ariharan Anantharachagan^{1

2}, Sook Yin Loh¹, Siobhan O Burns^{3

4}, Arian Laurence^{3

4

5}, Susan Tadros⁴, Eleni Tholouli⁶, Yadanar Lwin⁷, Nicolas Martinez-Calle⁷, P Vaitla⁸, Emma C Morris^{3

4

5}

Affiliations

¹ Department of Allergy and Clinical Immunology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, United Kingdom.
² Department of Immunology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, United Kingdom.
³ University College London Institute of Immunity and Transplantation, London, United Kingdom.
⁴ Department of Immunology, The Royal Free London NHS Foundation Trust, London, United Kingdom.
⁵ Department of Clinical Haematology, University College London NHS Foundation Trust, London, United Kingdom.
⁶ Manchester University NHS Foundation Trust, Department of Haematology, Manchester, United Kingdom.
⁷ Department of Haematology, Nottingham, United Kingdom.
⁸ Department of Immunology Nottingham University Hospitals, NHS Trust, Nottingham, United Kingdom.

Abstract

Regardless of their age, adult patients with Wiskott-Aldrich syndrome should be considered for hematopoietic stem cell transplantation if clinically indicated.

Keywords: HSCT; WAS; Wiskott-Aldrich syndrome; adult; hematopoietic stem cell transplantation.

Publication types

Case Reports